Related Experiment Videos
Effect of corticosteroids on cataract formation
Archives of Ophthalmology (Chicago, Ill. : 1960)
|October 1, 1980
Summary
Systemic corticosteroid therapy significantly increases posterior subcapsular cataract risk. However, individual susceptibility, not dose or duration, appears to be the primary factor in steroid-induced cataract formation.
Area of Science:
- Ophthalmology
- Pharmacology
- Endocrinology
Background:
- Corticosteroids are known to cause cataracts, but the specific dose-response relationship remains debated.
- Posterior subcapsular (PSC) cataracts are a known side effect of corticosteroid use.
Purpose of the Study:
- To investigate the correlation between systemic corticosteroid therapy and posterior subcapsular (PSC) cataract formation.
- To determine if total dose, intensity, or duration of corticosteroid administration influences PSC cataract incidence.
Main Methods:
- A study of 106 adult male patients, matched for age, race, and socioeconomic status.
- Comparison of PSC cataract incidence between patients with and without a history of systemic corticosteroid therapy.
Main Results:
- A statistically significant difference in PSC cataract incidence was observed between patients with and without corticosteroid history.
- No statistically significant correlation was found between PSC opacities and total steroid dose, weekly dose (intensity), duration, or patient age.
Conclusions:
- Systemic corticosteroid use is a significant risk factor for PSC cataract formation.
- Individual susceptibility to corticosteroid side effects may be the most critical factor in steroid-induced PSC cataract development.
- The concept of a "safe" corticosteroid dose for cataract prevention should be reconsidered.